IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2017 Holdings

Filed 2017-11-14 | 14 holdings | $10.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$10.1M191,60197.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$47.4K1,013,8470.5%
Gilead Sciences Inc(GILD)COM375558103$42.2K520,9240.4%
United Therapeutics Corp(UTHR)COM91307C102$40.6K346,5110.4%
Bioverativ IncCOM97075E100$35.9K629,5400.3%
Sucampo PharmaceuticalsCOM864909106$33.4K2,833,4160.3%
Merck & Co. Inc.(MRK)COM58933Y105$24.6K383,6150.2%
Orthofix International NVCOMN6748L102$23.0K487,1010.2%
Halyard Health IncCOM40650V100$21.6K478,6210.2%
RTI Surgical IncCOM74975N105$20.1K4,413,8210.2%
Invacare CorpCOM461203101$17.7K1,124,5280.2%
Aviragen Therapeutics IncCOM053761102$1.9K2,836,3260.0%
Digirad CorpCOM253827109$1.2K334,1790.0%
Juniper Pharmaceuticals IncCOM48203L107$1.1K243,1280.0%